SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-076454
Filing Date
2014-12-17
Accepted
2014-12-17 20:47:45
Documents
2
Period of Report
2014-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5398
2 POA DOCUMENT poa.txt EX-24.3_550260 3160
  Complete submission text file 0001209191-14-076454.txt   10234
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2101 CEDAR SPRINGS ROAD, SUITE 601 DALLAS TX 75201
Business Address 2101 CEDAR SPRINGS ROAD, SUITE 601 DALLAS TX 75201 (214) 506-2662
Remeditex Ventures LLC (Reporting) CIK: 0001627363 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 141294029